Description: Before entering into an agreement or contract with another party it is always advisable to investigate precisely the situation, products, companies that you want to buy or companies that you want work with in the future. In order to make a reasonable Due Diligence (DD) several internal stakeholders are needed that contribute by reviewing the available information. Finally, after having determined pros and cons, it is mostly the strategic and financial view on the project that is the basis for a decision. With these two presentations you will learn to see the situation from both sides, a financial Mergers & Acquisitions perspective and a regulatory/quality perspective with examples in the context of software. To understand the thinking and view of financial expert will help you as RA or QA to present your data efficiently and argue in an adequate way. RA & QA are of critical importance to support company or product acquisitions by assessing and evaluating available data. Any regulatory gaps in such data, or any gaps in the QA/QMS processes applied during the generation of such data, could potentially diminish the value of the data which could risk or prolong market access with potential financial impact. Therefore, smart Pharma, Biotech, and Medtech companies include RA & QA in the core team of their DD process to increase the financial predictability of M&A business transactions.
Learning Objectives:
Learn to see the DD situation from a financial perspective and Mergers & Acquisitions view
Insides into the financial techniques and approach for a DD
With this understand the critical information that RA & QA need to provide to the DD core team such that the DD Core team can present a substantiated recommendation/advice to the CEO or the board of directors on the business transaction under consideration.
